Broad-Spectrum Antimicrobial Activity of a New Triazenoimidazole
AUTOR(ES)
Pittillo, Robert F.
RESUMO
Methyl-5(or 4)-(3,3-dimethyl-1-triazeno)-imidazole-4(or 5)-carboxylate was shown to have in vitro antimicrobial activity against gram-positive and gram-negative bacteria, yeasts, filamentous fungi, and algae. Preliminary studies with mice, experimentally infected with Staphylococcus aureus, have shown that this new antimicrobial agent has in vivo chemotherapeutic activity comparable to that observed with penicillin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=546961Documentos Relacionados
- Broad-spectrum antimicrobial activity of human intestinal defensin 5.
- Pirbenicillin, a New Semisynthetic Penicillin with Broad-Spectrum Activity
- Cefadroxil, a New Broad-Spectrum Cephalosporin
- Pharmacokinetics of Cefonicid, a New Broad-Spectrum Cephalosporin
- Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
